Intensity Modulated Radiation Therapy Market - Radiation Type (Proton, Electron, Photon, Carbon-ion), Application (Prostate, Lung, Breast, Brain, & Gynecological Cancer), End use (Hospital, Standalone Radiation Therapy Center)- Global Forecast, 2023-2032

Intensity Modulated Radiation Therapy Market - Radiation Type (Proton, Electron, Photon, Carbon-ion), Application (Prostate, Lung, Breast, Brain, & Gynecological Cancer), End use (Hospital, Standalone Radiation Therapy Center)- Global Forecast, 2023-2032

Intensity modulated radiation therapy market size is projected to expand at 5.2% from 2023 to 2032. The increasing incidence of cancer globally is fueling the demand for advanced and precise treatment methods. Intensity modulated radiation therapy offers enhanced accuracy in targeting tumors while minimizing damages to surrounding healthy tissues, leading to its widespread adoption. For instance, in October 2023, UT health San Antonio launched Pluvicto, an FDA-approved radiopharmaceutical to provide radiation treatment therapy specifically to prostate-specific membrane antigen positive (PSMA+) metastatic castration-resistant prostate cancer.

The influx of supportive government initiatives, rising investments in healthcare infrastructure, and the continuous development of innovative radiation therapy solutions are catering to the evolving needs of cancer patients and healthcare providers. Additionally, the rising awareness of the benefits of intensity modulated radiation therapy (IMRT), such as reduced side effects and improved treatment outcomes, will fuel the industry growth.

The intensity modulated radiation therapy market is segregated into radiation type, application, end-use, and region.

The industry share from the electron radiation therapy segment is projected to rise at 5.3% CAGR from 2023 to 2032. The growth is attributed to the precision and effectiveness of electron radiation in treating superficial tumors. This modality offers improved targeting and minimizes damages to the surrounding healthy tissues. The growing demand for advanced and targeted cancer treatments will also drive the segment growth.

Based on application, the intensity modulated radiation therapy market size from the gynecological cancer segment is projected to depict 5.1% CAGR during 2023-2032. This is ascribed to the increasing incidence of gynecological cancers, high demand for precise and targeted radiation therapy, and the advancements in treatment planning. The ability of IMRT to deliver focused radiation while sparing healthy tissues will also contribute to its adoption for treating gynecological cancers.

Regionally, the Asia Pacific intensity modulated radiation therapy market is projected to expand at 5.8% CAGR from 2023 to 2032. This is due to the increasing prevalence of cancer, rising awareness of advanced treatment options, and the improving healthcare infrastructure. The adoption of cutting-edge technologies, the increasing government initiatives, and the growing demand for personalized cancer care will also boost the regional market expansion. Show more